Lung cancer, the leading cause of cancer related mortality. Among them, non small cell lung cancer accounts for 85%. Only part of patients could be treated with radical surgery, and some patients were unfit for surgery due to the poor cardio-pulmonary function or refuse surgery. For those patients, microwave ablation (MWA) could be an alternative treatment. Several small sample retrospective studies verified that MWA could be an efficacy and safe treatment.
Patients with stage I non small cell lung cancer unfit for or refused surgery will be treated with MWA in the primary tumor sites.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
150
eligible patients will be treated with microwave ablation in the primary tumor sites
Shandong Provincial Hospital
Jinan, Shandong, China
Shandong Provincial Hospital affliated to Shandong University
Jinan, Shandong, China
Overall survival
Time frame: From the date of randomization until the date of death from any cause,assessed up to 36 months
Disease free survival
Time frame: From the date of randomization until the date of first documented progression,assessed up to 36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.